retractable.com (RVP): Debts to Book Capitalization

Graphic logo of Retractable Technologies, Inc. (RVP)

The ratio of total debt to equity for Retractable Technologies (RVP) demonstrates steady dynamics, with the parameter value equal to 0.01. Stability is underpinned by long-term government contracts and predictable cash flow. High margins are based on VanishPoint patents and inelastic demand. Current growth relies on the monetization of a proven form factor for auto-retractable syringes, which minimizes risks for physicians.

Retractable Technologies Inc. - RVP Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Core merchandise of retractable.com

This ratio compares total debt obligations to the book value of equity to assess financial stability. The metric determines the business's degree of dependence on external financing and the associated default risks. By analyzing the debt-to-book capitalization ratio, an investor evaluates the effectiveness of leverage management. For Retractable Technologies (RVP), steady demand for medical consumables allows the company to maintain a safe debt level. This confirms the reliability of Retractable Technologies (RVP) as it diversifies its distribution channels.

Who Retractable Technologies competes with

Debts to Book Capitalization ISRG|Debts to Net Assets danaher.com DHR|BDX: Debts to Book Capitalization|STE - Debt to Book Value|WST: Debts to Book Capitalization|BAX (Baxter Healthcare) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Masimo Corporation|Debt to Book Capitalization Ratio stevanatogroup.com (STVN)|Teleflex (TFX) - Debt to Book Value|Debt to Net Assets Ratio Merit Medical Systems, Inc. (MMSI)|Debts to Book Capitalization NVST|ICU Medical Inc. - Debts to Net Assets|DENTSPLY SIRONA Inc. (XRAY) - Debt to Book Capitalization Ratio|LMAT: Debt to Book Value Ratio|AtriCure - Debt to Book Capitalization Ratio|Debts to Net Assets STAAR Surgical Co.|Chromadex Corp (NAGE) - Debt to Book Value|Debt to Book Capital ZIMV|AngioDynamics, Inc. (ANGO) - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio cerus.com CERS|Debt to Book Value TKNO (Teknova)|Monogram Technologies Inc. - Debts to Book Capitalization|STSS: Debt to Book Capitalization Ratio|INFU - Debt to Book Value|Debts to Book Capitalization UTMD|KRMD (KORU Medical) - Debts to Book Value|Debt to Book Capitalization Ratio Nyxoah (NYXH)|Debt to Book Value Ratio Microbot Medical, Inc. (MBOT)|Debt to Book Value Pro-Dex Corp|Debt to Book Capital ZTEK (Zentek Corp)|Debt to Book Capitalization Ratio ELUT|milestonescientific.com - Debts to Net Assets|Debt to Book Capitalization Ratio NEXGEL (NXGL)|HBIO - Debt to Net Assets Ratio|Debts to Book Capitalization FEMY|Debts to Book Value Meihua Medical Technologies Co., Ltd.|Predictive Oncology Inc (POAI) - Debt to Book Value|Debt to Book Capital CJMB|Atrion (ATRI) - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio NeuroMetrix Inc (NURO)